Search

everythinglearnresearchcommunity

for

Search:↓

Some plants with flavonoids may help treat hair loss and promote hair growth.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Tailor treatments for vitiligo to patient needs for best results.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Cyperus rotundus oil effectively reduces unwanted hair without side effects.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Some topical treatments like corticosteroids and vitamin D analogues are effective for scalp psoriasis, but more long-term data is needed.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Alopecia areata patients have lower zinc, copper, and selenium levels than healthy people.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

The article concludes that different types of hair loss require specific treatments and psychological support is important.